...
首页> 外文期刊>Cytotechnology >A serum substitute for fed-batch culturing of hybridoma cells
【24h】

A serum substitute for fed-batch culturing of hybridoma cells

机译:杂交瘤细胞补料分批培养的血清替代品

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

We developed a substitute for serum to produce fed-batch cultures of hybridoma cells in serum-free medium and confirmed that the cells could be successfully cultivated this way. Our substitute consisted of 12 components. The specific production rates of lactate and ammonia, which are harmful byproducts from the cells, were significantly reduced compared with a conventional serum-containing batch culture. This reduction led to a higher cell concentration and a longer production lifetime. As a result, the final concentration of monoclonal antibody was 400 mg/L, or five times greater than that in the conventional serum-containing batch culture. The developed substitute is expected to enable fed-batch cultivation in a serum-free condition.
机译:我们开发了一种血清替代品,可以在无血清培养基中生产杂交瘤细胞的补料分批培养,并证实可以用这种方法成功培养细胞。我们的替代品包括12个成分。与常规的含血清分批培养相比,乳酸和氨(它们是细胞的有害副产物)的特定生产率显着降低。这种减少导致更高的细胞浓度和更长的生产寿命。结果,单克隆抗体的终浓度为400 mg / L,或比常规的含血清分批培养的终浓度高五倍。开发的替代品有望在无血清条件下进行分批补料培养。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号